Governments around the world are taking various approaches to address these regulatory challenges. Regulatory agencies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are actively working on developing specific guidelines for nanotechnology. Collaborative efforts between countries are also being pursued to harmonize regulations globally. Public consultations and stakeholder engagements are integral to these processes, ensuring diverse perspectives are considered.
